Head of Quintiles’ clinical development business is retiring

Paula Brown Stafford, who heads the largest business unit at pharmaceutical services giant Quintiles, is retiring at the end of the month.

Stafford, who was the Durham-based company’s 23rd employee when she joined the business in 1985 – three years after it was founded – has been president of clinical development since 2010. Today Quintiles has nearly 35,000 employees worldwide, including more than 20,000 in the clinical development unit.

“She has made an extraordinary contribution to Quintiles’ growth over the course of three decades in a wide variety of roles and geographies,” said company spokesman Phil Bridges.

Bridges added that Stafford, 51, “plans to spend focused time with her family and dedicate more of her time and talents to a number of non-profits about which she is passionate. She has made a tremendous impact at Quintiles and we wish her every happiness.”

Quintiles, the world's largest contract research organization, helps drug companies test experimental medicines and analyze the results. It also assists those companies with selling and marketing prescription medicines after they win regulatory approval.